Validation of the Oxford classification of IgA nephropathy for pediatric patients from China

BMC Nephrology

Zhi-Hong Liu³  Agnes B Fogo⁸  Jianming Wang⁵  Hongbing Shen⁵  Qian Huang³  Feng Xu³  Hao Chen³  Shaoshan Liang³  Xiaoqing Yang²  Ying Ding²  Yihui Zhai⁴  Hong Xu⁴  Ying Wu⁶  Guanghua Zhu⁶  Zhong-Min Fan⁷  Zheng-Kun Xia⁷  Rui-Xia Lin¹  Qing Yang¹  Dong Liu⁹  Zhangsuo Liu⁹  Cai-Hong Zeng³  Weibo Le³ 

[1] Department of Nephrology, Yuying Children’s Hospital Affiliated to Wenzhou Medical College, Wenzhou, Zhejiang, China;Department of Pediatrics, The first affiliated hospital of henan college of TCM, Zhengzhou, China;Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;Department of Nephrology and Rheumatology, Children’s Hospital of Fudan University, Shanghai, China;Department of Epidemiology and Biostatistics & Ministry of Education Key Lab for Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China;Department of Nephrology and Rheumatology, Children’s Hospital of Shanghai Jiaotong University, Shanghai, China;Department of Pediatrics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA;Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

关键词: Pediatrics;    Children;    Oxford classification;    IgA nephropathy;    Glomerulonephritis;   

Others  :  1083053
DOI  :  10.1186/1471-2369-13-158

 received in 2012-04-27, accepted in 2012-11-18,  发布年份 2012

【 摘 要 】

Background

The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.

Methods

A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.

Results

There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).

Conclusions

We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.

【 授权许可】

   
2012 Le et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]D’Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004, 24(3):179-196.
• [2]Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z: Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 2012, 27(4):1479-1485.
• [3]Haas M: Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997, 29(6):829-842.
• [4]Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997, 8(2):199-207.
• [5]Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI: IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982, 13(4):314-322.
• [6]Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009, 24(10):3068-3074.
• [7]Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M, Schena FP: A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007, 49(6):763-775.
• [8]Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, et al.: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009, 76(5):534-545.
• [9]Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, et al.: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009, 76(5):546-556.
• [10]Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M: Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant 2006, 21(12):3466-3474.
• [11]Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM: IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 2008, 23(8):2537-2545.
• [12]Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, et al.: The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010, 77(10):921-927.
• [13]Mina SN, Murphy WM: IgA nephropathy. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol 1985, 83(6):669-675.
• [14]Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y: IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol 1990, 10(3):191-197.
• [15]Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, et al.: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol 2011, 6(9):2175-2184.
• [16]Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, et al.: Validation of the Oxford classification of IgA nephropathy. Kidney Int 2011, 80(3):310-317.
• [17]Edstrom Halling S, Soderberg MP, Berg UB: Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Nephrol Dial Transplant 2012, 27(2):715-722.
• [18]Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C: The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol 2011, 6(10):2384-2388.
• [19]Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, Kaito H, Sako M, Iijima K, Yoshikawa N: Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol 2012, 27(5):783-792.
• [20]Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ: The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol 2011, 34(5):435-444.
• [21]Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, et al.: A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis 2012, 60(5):812-820.
• [22]Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, et al.: The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant 2012, 27(1):252-258.
• [23]D’Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al.: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986, 59(228):363-378.
• [24]El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 2011, 79(6):643-654.
• [25]Liu LJ, Li GT, Zhou Y, Lv JC, Zhang H: Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy. Nephron Clin Pract 2010, 115(2):c161-c167.
• [26]Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH: Validation of the oxford classification of IgA nephropathy: a single-center study in korean adults. Korean J Intern Med 2012, 27(3):293-300.
• [27]D’Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G: Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int 2001, 59(2):682-692.
• [28]Hotta O, Furuta T, Chiba S, Tomioka S, Taguma Y: Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis 2002, 39(3):493-502.
• [29]Katafuchi R, Ninomiya T, Nagata M, Mitsuiki K, Hirakata H: Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol 2011, 6(12):2806-2813.
• [30]Barratt J, Feehally J: Primary IgA Nephropathy: new insights into pathogenesis. Semin Nephrol 2011, 31(4):349-360.